☆ 4.6 Review

Novel Anti-Inflammatory Therapies in Coronary Artery Disease and Acute Coronary Syndromes

LIFE-BASEL (2023)

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Inflammageing and Cardiovascular System: Focus on Cardiokines and Cardiac-Specific Biomarkers

Marco Alfonso Perrone et al.

Summary: The term inflammageing was introduced in 2000 to describe the chronic inflammatory state of elderly individuals, which is characterized by elevated levels of inflammatory biomarkers, comorbidities, disability, frailty, and premature death. Inflammageing is linked to various cardiovascular diseases and early detection and counteraction of inflammageing can prevent cardiovascular disease and slow down age-related health decline. Early interventions require reliable and cost-effective biomarkers, such as cardiac-specific biomarkers, for diagnosis and further clinical studies are needed to assess their usefulness and cost/benefit ratio.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection
Review Biochemistry & Molecular Biology

Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment

Stamatios Lampsas et al.

Summary: Lp(a) is a cholesterol-like particle associated with apolipoprotein(a) and is a heritable risk factor for ASCVD. It plays a crucial role in inflammation, atherosclerosis, and thrombosis, but its measurement lacks a standardized method across laboratories. Standard antilipidemic therapies have limited effects on Lp(a) levels, and their impact on CV events and prognosis remains unclear.

MOLECULES (2023)

Add to Collection
Article Cardiac & Cardiovascular Systems

Biomarker Concentrations and Their Temporal Changes in Patients With Myocardial Infarction and Nonobstructive Compared With Obstructive Coronary Arteries: Results From the PLATO Trial

Marcus Hjort et al.

Summary: Investigating biomarker concentrations and their changes can provide new insights into the pathobiology of nonobstructive myocardial infarction (MINOCA). Patients with MINOCA have higher initial inflammatory activity, similar myocardial dysfunction, and faster recovery compared to those with MI with obstructive coronary artery disease.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Add to Collection
Review Cardiac & Cardiovascular Systems

Fundamental Pathobiology of Coronary Atherosclerosis and Clinical Implications for Chronic Ischemic Heart Disease Management-The Plaque Hypothesis A Narrative Review

Peter H. Stone et al.

Summary: Recent studies have shown that major adverse cardiac events (MACE) are not only caused by severe coronary obstructions, but also by plaque burden along the entire coronary tree. However, the translation of these findings into clinical management strategies needs further research.

JAMA CARDIOLOGY (2023)

Add to Collection
Article Cardiac & Cardiovascular Systems

Association of Interleukin 6 Inhibition With Ziltivekimab and the Neutrophil-Lymphocyte Ratio A Secondary Analysis of the RESCUE Clinical Trial

Nicholas H. Adamstein et al.

Summary: This post hoc analysis found that ziltivekimab can reduce the neutrophil-lymphocyte ratio (NLR), suggesting its potential in disrupting multiple atherogenic inflammatory pathways. Monitoring the NLR may be helpful in assessing the efficacy of ziltivekimab if it is introduced into clinical practice.

JAMA CARDIOLOGY (2023)

Add to Collection
Review Cardiac & Cardiovascular Systems

Inflammation in coronary artery disease-clinical implications of novel HDL-cholesterol-related inflammatory parameters as predictors

Xuantong Guo et al.

Summary: Coronary artery disease (CAD) is the leading cause of death globally, primarily due to inflammation and atherosclerotic plaques. Inflammatory cells and mediators are used to identify inflammatory risk in CAD patients. HDL-cholesterol has been shown to have anti-inflammatory roles by interfering with immune cells' plasma membrane lipid rafts. Novel inflammatory parameters, such as the monocyte to HDL-C ratio, are being explored to improve risk estimation of CAD prognosis.

CORONARY ARTERY DISEASE (2023)

Add to Collection
Review Immunology

Interactions between PCSK9 and NLRP3 inflammasome signaling in atherosclerosis

Yanan Wang et al.

Summary: Atherosclerosis is an early pathological basis of cardiovascular events resulting in death or disability. Recent studies have identified PCSK9 as a target for atherosclerosis treatment, as it degrades LDLR and acts as an inflammatory modulator. The NLRP3 inflammasome plays a key role in atherosclerotic disease, and interactions between PCSK9 and NLRP3 inflammasome contribute to inflammation-driven development and progression of atherosclerosis.

FRONTIERS IN IMMUNOLOGY (2023)

Add to Collection
Review Nutrition & Dietetics

Anti-Inflammatory Effects of Lipid-Lowering Drugs and Supplements-A Narrative Review

Stefan Zivkovic et al.

Summary: Cardiovascular diseases (CVD) are the leading cause of death worldwide. Lipid-lowering agents used in the treatment of CVD may also have anti-inflammatory and immunomodulatory properties. This review aims to evaluate the anti-inflammatory properties of currently available lipid-lowering medications, dietary supplements, and novel drugs.

NUTRIENTS (2023)

Add to Collection
Article Cardiac & Cardiovascular Systems

Association of plasma interleukin-6 with infarct size, reperfusion injury, and adverse remodelling after ST-elevation myocardial infarction

Christina Tiller et al.

Summary: This study found that elevated plasma IL-6 levels on Day 2 after STEMI were associated with worsened myocardial function, larger infarct size, more severe reperfusion injury, and an increased risk of adverse left ventricular remodeling.

EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2022)

Add to Collection
Article Medicine, General & Internal

Predictive value of HDL function in patients with coronary artery disease: relationship with coronary plaque characteristics and clinical events

Marco Magnoni et al.

Summary: The study found that SR-BI-mediated cholesterol efflux is significantly reduced in patients with CAD, while ABCA1-mediated cholesterol efflux is similar among all groups. In CAD patients, SR-BI-mediated cholesterol efflux <25th percentile predicted cardiovascular outcomes, whereas ABCA1-mediated cholesterol efflux and HDL-C levels did not. Despite reduced SR-BI-mediated cholesterol efflux, there were no changes in high-risk plaque features or prevalence of elevated plaque volume.

ANNALS OF MEDICINE (2022)

Add to Collection
Article Immunology

MCC950 in the treatment of NLRP3-mediated inflammatory diseases: Latest evidence and therapeutic outcomes

Saba Bakhshi et al.

Summary: Evidence suggests that NLRP3 is involved in various inflammatory and autoimmune diseases, and inhibition of NLRP3 can be a useful treatment option. MCC950, a small molecule, can specifically inhibit NLRP3 and reduce the production of proinflammatory cytokines.

INTERNATIONAL IMMUNOPHARMACOLOGY (2022)

Add to Collection
Article Cardiac & Cardiovascular Systems

Coronary Atherosclerosis, Cardiac Troponin, and Interleukin-6 in Patients With Chest Pain The PROMISE Trial Results

Maros Ferencik et al.

Summary: This study found that biomarkers of inflammation and myocardial injury were associated with characteristics of coronary artery disease (CAD) and major adverse cardiovascular events (MACEs), and the association was most pronounced in patients with nonobstructive CAD. These findings provide an opportunity for personalized treatment in high-risk populations.

JACC-CARDIOVASCULAR IMAGING (2022)

Add to Collection
Review Cardiac & Cardiovascular Systems

The Role of Interleukin-6 Family Members in Cardiovascular Diseases

Yongqi Feng et al.

Summary: This review discusses the role of IL-6 family members in cardiovascular disease, providing relevant information for identifying intervention targets for cardiovascular disease prevention and treatment.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Add to Collection
Review Immunology

The effect of combination therapy with statins and ezetimibe on proinflammatory cytokines: A systematic review and meta-analysis of randomized controlled trials

Seyyed Mostafa Arabi et al.

Summary: This systematic review and meta-analysis evaluates the impact of combination therapy with statins and ezetimibe on proinflammatory cytokines. The results indicate that the combination therapy does not significantly reduce IL-1 beta, TNF-alpha, and MCP-1, but shows significant reductions in IL-6 and IFN-gamma levels. Furthermore, the reduction in IL-6 is particularly significant among individuals aged >= 60 years and the Asian population.

INTERNATIONAL IMMUNOPHARMACOLOGY (2022)

Add to Collection
Review Biochemistry & Molecular Biology

The Impact of Cytokines in Coronary Atherosclerotic Plaque: Current Therapeutic Approaches

Panagiotis Tsioufis et al.

Summary: Coronary atherosclerosis is a chronic disease involving inflammation, endothelial dysfunction, and lipoprotein dysregulation. Inflammatory cytokines, such as interleukins, tumor necrosis factor-alpha, and chemokines, play a role in the development and progression of coronary artery disease. Targeting these cytokines with drugs like IL-1 beta and colchicine has shown promise in reducing cardiovascular risk. Other cytokine-targeted treatments are being explored, but more research is needed.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection
Article Nanoscience & Nanotechnology

Targeted Therapy of Atherosclerosis Vulnerable Plaque by ROS-Scavenging Nanoparticles and MR/Fluorescence Dual-Modality Imaging Tracing

Yue Dai et al.

Summary: In this study, integrated diagnosis and treatment nanoparticles based on Gd-doped Prussian blue (GPB) were developed for the fluorescence/MR dual-mode imaging and anti-ROS treatment of vulnerable atherosclerosis (AS) plaques. The fabricated nanoparticles showed excellent imaging ability and effectively inhibited AS progression by scavenging ROS, reducing inflammation, apoptosis, and the formation of foam cells. This study provides a new avenue for the diagnosis and treatment of vulnerable AS plaques.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2022)

Add to Collection
Article Cardiac & Cardiovascular Systems

COlchicine to Prevent PeriprocEdural Myocardial Injury in Percutaneous Coronary Intervention (COPE-PCI): A Descriptive Cytokine Pilot Sub-Study

Justin Cole et al.

Summary: This study aimed to determine if administration of colchicine pre-PCI could attenuate the inflammatory effect of PCI. The results showed that colchicine patients had lower levels of pre-PCI cytokines, but there was no difference in post-PCI inflammation between the treatment arms.

CARDIOVASCULAR REVASCULARIZATION MEDICINE (2022)

Add to Collection
Review Chemistry, Medicinal

Interleukin-1 in Coronary Artery Disease

Evangelos Oikonomou et al.

Summary: This article discusses the crucial role of interleukin-1 in the progression of atherosclerosis, the inflammatory cascade, and the clinical application of targeted anti-inflammatory treatments.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2022)

Add to Collection
Review Chemistry, Medicinal

Lipoprotein-associated Phospholipase A2 in Coronary Artery Disease

Yannis Dimitroglou et al.

Summary: Lipoprotein-associated phospholipase A2 (Lp-PLA2) plays a significant role in coronary artery disease, but randomized trials have failed to establish its effectiveness as a therapeutic target.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2022)

Add to Collection
Article Endocrinology & Metabolism

Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS

Akihiko Koshino et al.

Summary: This study evaluated the association of interleukin-6 (IL-6) with cardiovascular and kidney outcomes in patients with type 2 diabetes and investigated the effect of canagliflozin on IL-6 level. The results showed that baseline IL-6 level and its 1-year change were associated with cardiovascular and kidney outcomes. Canagliflozin slightly attenuated the increase of IL-6 level. Further research is needed to examine the impact of IL-6-lowering therapy on cardiovascular, kidney, and safety outcomes.

DIABETES CARE (2022)

Add to Collection
Review Immunology

The effect of statin therapy in combination with ezetimibe on circulating C-reactive protein levels: a systematic review and meta-analysis of randomized controlled trials

Seyyed Mostafa Arabi et al.

Summary: This study conducted a systematic review and meta-analysis to evaluate the effect of statin therapy in combination with ezetimibe on CRP and hs-CRP levels. The results showed that the combination therapy significantly reduced the levels of hs-CRP and overall CRP, suggesting its potential in suppressing inflammation.

INFLAMMOPHARMACOLOGY (2022)

Add to Collection
Review Immunology

How the immune system shapes atherosclerosis: roles of innate and adaptive immunity

Payel Roy et al.

Summary: Atherosclerosis involves an inappropriate inflammatory response, with crucial roles played by immune cells. Understanding the regulatory mechanisms of immune cells in atherosclerosis is crucial for developing therapeutic interventions.

NATURE REVIEWS IMMUNOLOGY (2022)

Add to Collection
Review Cardiac & Cardiovascular Systems

Systematic Review/Meta-analysis Colchicine for Secondary Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Michelle Samuel et al.

Summary: Low-dose colchicine has shown significant efficacy in reducing cardiovascular events among patients with coronary artery disease in randomized controlled trials, particularly in reducing the incidence of myocardial infarction, ischemic stroke, and urgent coronary revascularizations. Safety outcomes did not differ significantly between groups.

CANADIAN JOURNAL OF CARDIOLOGY (2021)

Add to Collection
Review Cardiac & Cardiovascular Systems

Role of Lipid Accumulation and Inflammation in Atherosclerosis: Focus on Molecular and Cellular Mechanisms

Khojasteh Malekmohammad et al.

Summary: Atherosclerosis is a chronic inflammatory disease driven by lipid accumulation, especially low-density lipoprotein, and dysfunction of lipid homeostasis. Inflammation plays a key role in all phases of atherosclerosis, while lipid metabolism and inflammatory pathways interact closely with each other. Studies have shown that microRNAs and lncRNAs also have important regulatory roles in the pathophysiology of atherosclerosis.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Add to Collection
Article Cardiac & Cardiovascular Systems

Colchicine reduces extracellular vesicle NLRP3 inflammasome protein levels in chronic coronary disease: A LoDoCo2 biomarker substudy

Max J. M. Silvis et al.

Summary: The study showed that colchicine reduces EV NLRP3 protein levels in patients with chronic coronary disease, as well as lowering serum inflammatory marker hs-CRP levels, suggesting that inhibitory effects on NLRP3 inflammasome may contribute to the atheroprotective effects of colchicine in coronary disease.

ATHEROSCLEROSIS (2021)

Add to Collection
Article Cardiac & Cardiovascular Systems

Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial

Mehdi Akrami et al.

Summary: Colchicine, as an anti-inflammatory drug, significantly reduces MACE occurrence and improves survival rate in ACS patients over time according to the trial conducted on 249 patients between October 2019 to March 2020. The study showed a lower MACE rate in the colchicine group compared to the placebo group, with gastrointestinal symptoms being the most common side effect.

BMC CARDIOVASCULAR DISORDERS (2021)

Add to Collection
Review Medicine, General & Internal

Effect of low-dose colchicine in acute and chronic coronary syndromes: A systematic review and meta-analysis

Alberto Aimo et al.

Summary: Colchicine therapy significantly reduced the risk of cardiovascular events in CCS patients compared to placebo, and showed a trend towards reducing the risk in ACS patients as well. Additionally, colchicine tended to reduce the increase of hs-CRP levels compared to placebo.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection
Article Cardiac & Cardiovascular Systems

Interferon-γ Impairs Human Coronary Artery Endothelial Glucose Metabolism by Tryptophan Catabolism and Activates Fatty Acid Oxidation

Laurel Yong-Hwa Lee et al.

Summary: The study found that exposure to IFN-gamma impairs endothelial glucose metabolism by altering tryptophan catabolism, destabilizing HIF1, depleting nicotinamide adenine dinucleotide, and shifting towards increased fatty acid oxidation. These metabolic disturbances were associated with adverse endothelial phenotypic changes, including decreased basal intracellular cGMP, impaired endothelial migration, and a switch to a proinflammatory state.

CIRCULATION (2021)

Add to Collection
Article Urology & Nephrology

Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Pablo E. Pergola et al.

Summary: Ziltivekimab significantly improved markers of inflammation, reduced ESA requirements, and increased serum albumin in hemodialysis patients with inflammation and hyporesponsiveness to ESA therapy.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Add to Collection
Review Biochemistry & Molecular Biology

Inflammation in Coronary Microvascular Dysfunction

Marios Sagris et al.

Summary: Chronic low-grade inflammation plays a role in coronary atherosclerosis, leading to a range of clinical manifestations. Microvascular dysfunction in the coronary arteries can reduce oxygen supply to the myocardium. Anti-inflammatory agents may offer new treatment approaches for reducing cardiovascular events.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection
Review Cell Biology

Inflammatory Chemokines in Atherosclerosis

Selin Gencer et al.

Summary: Atherosclerosis is a chronic inflammatory disease of the vessel wall leading to occlusive lesions in large arteries. Chemokines and their receptors play a key role in the development of atherosclerotic lesions by orchestrating immune cell activation and recruitment. Recent research has focused on targeting these chemokines for potential treatment of atherosclerosis.

CELLS (2021)

Add to Collection
Review Immunology

An update on the regulatory mechanisms of NLRP3 inflammasome activation

Seungwha Paik et al.

Summary: This review article discusses the molecular details of NLRP3 inflammasome activation, focusing on priming/licensing and assembly steps, as well as protein-protein interactions, posttranslational modifications, and spatiotemporal regulation of the NLRP3 inflammasome machinery. Multiple positive and/or negative regulatory pathways providing upstream signals for NLRP3 inflammasome complex assembly are also summarized, with the ultimate goal of developing methods for the prevention and treatment of NLRP3 inflammasome-related diseases.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Add to Collection
Review Cardiac & Cardiovascular Systems

Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease

Paul M. Ridker et al.

Summary: IL-6 is a pivotal cytokine in innate immunity with a proatherogenic role in cardiovascular disease. Research has explored mechanisms of IL-6 signaling, murine models, and human epidemiological data regarding its utility as a biomarker of vascular risk.

CIRCULATION RESEARCH (2021)

Add to Collection
Review Immunology

The role of interleukin-10 family members in cardiovascular diseases

Shuwan Xu et al.

Summary: Members of the IL-10 cytokine family, such as IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28A, IL-28B, and IL-29, play critical roles in regulating inflammation, which is closely associated with the occurrence and progression of cardiovascular diseases. Studies have focused on the relationship between the IL-10 cytokine family and cardiovascular diseases, aiming to determine their contribution to disease regulation.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Add to Collection
Article Cardiac & Cardiovascular Systems

Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction

Kaspar Broch et al.

Summary: The study showed that tocilizumab, an interleukin-6 receptor inhibitor, increased myocardial salvage in patients with acute STEMI, reduced microvascular obstruction, but did not significantly decrease final infarct size.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Add to Collection
Article Medicine, General & Internal

IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial

Paul M. Ridker et al.

Summary: This study investigated the safety and efficacy of IL-6 inhibition treatment in high cardiovascular risk individuals. Results showed that ziltivekimab effectively reduced biomarkers of inflammation and thrombosis, with promising effects observed in patients with chronic kidney disease.

LANCET (2021)

Add to Collection
Article Cardiac & Cardiovascular Systems

Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction

Nathan Mewton et al.

Summary: A study in patients with reperfused ST-segment-elevation myocardial infarction showed that oral administration of high-dose colchicine for 5 days did not reduce myocardial damage and left ventricular remodeling.

CIRCULATION (2021)

Add to Collection
Article Cardiac & Cardiovascular Systems

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)

Frank L. J. Visseren et al.

EUROPEAN HEART JOURNAL (2021)

Add to Collection
Review Biochemistry & Molecular Biology

Treg cells in atherosclerosis

Rebecca Kuan et al.

Summary: Regulatory T (Treg) cells play a crucial role in atherosclerotic diseases by inhibiting inflammation and modulating lipid metabolism to affect the progression of atherosclerosis.

MOLECULAR BIOLOGY REPORTS (2021)

Add to Collection
Article Nutrition & Dietetics

Usefulness of MCP-1 Chemokine in the Monitoring of Patients with Coronary Artery Disease Subjected to Intensive Dietary Intervention: A Pilot Study

Magdalena Makarewicz-Wujec et al.

Summary: The study evaluated the impact of the DASH diet on MCP-1 plasma concentration in patients with coronary artery disease, finding a significant decrease in MCP-1 levels, correlated with changes in vitamin C and dietary fiber intake, reflecting alterations in atheroma volume and composition ratios of coronary plaque components.

NUTRIENTS (2021)

Add to Collection
Article Cardiac & Cardiovascular Systems

Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome

Gorav Batra et al.

Summary: Elevated IL-6 levels are associated with increased risk of major adverse cardiovascular events in patients with chronic coronary syndrome, particularly in the presence of chronic kidney disease. This suggests that IL-6 and CKD stage could be useful markers for identifying patients who may benefit from anti-inflammatory treatment in the context of chronic coronary syndrome.

JAMA CARDIOLOGY (2021)

Add to Collection
Review Biochemistry & Molecular Biology

Inflammatory Mechanisms Contributing to Endothelial Dysfunction

Panagiotis Theofilis et al.

Summary: Maintenance of endothelial cell integrity is crucial for human health, as dysfunction can lead to various diseases. Activated and injured endothelial cells release inflammatory mediators and enter a pro-thrombotic state, ultimately promoting atherosclerosis progression. Various pathways and mechanisms contribute to endothelial dysfunction, highlighting the complexity of this process.

BIOMEDICINES (2021)

Add to Collection
Article Cell Biology

The in vitro effect of antirheumatic drugs on platelet function

Camilla Brodsgaard Nielsen et al.

PLATELETS (2020)

Add to Collection
Article Engineering, Biomedical

Targeted delivery of anti-inflammatory cytokine by nanocarrier reduces atherosclerosis in Apo E-/- mice

Manse Kim et al.

BIOMATERIALS (2020)

Add to Collection
Review Genetics & Heredity

Association of tumor necrosis factor-α gene polymorphisms and coronary artery disease susceptibility: a systematic review and meta-analysis

Rui Huang et al.

BMC MEDICAL GENETICS (2020)

Add to Collection
Article Cardiac & Cardiovascular Systems

Effects of Acute Colchicine Administration Prior to Percutaneous Coronary Intervention COLCHICINE-PCI Randomized Trial

Binita Shah et al.

CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2020)

Add to Collection
Article Hematology

Pathologic Disparities Between Peripheral Artery Disease and Coronary Artery Disease

Nupoor Narula et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)

Add to Collection
Review Cardiac & Cardiovascular Systems

A link between inflammation and thrombosis in atherosclerotic cardiovascular diseases: Clinical and therapeutic implications

Evangelos Oikonomou et al.

ATHEROSCLEROSIS (2020)

Add to Collection
Article Biotechnology & Applied Microbiology

Blood Monocyte Phenotype Fingerprint of Stable Coronary Artery Disease: A Cross-Sectional Substudy of SMARTool Clinical Trial

Silverio Sbrana et al.

BIOMED RESEARCH INTERNATIONAL (2020)

Add to Collection
Review Cell Biology

The role of interferon-γ in cardiovascular disease: an update

Ailin Elyasi et al.

INFLAMMATION RESEARCH (2020)

Add to Collection
Article Medicine, General & Internal

Anti-atherogenic Modification of Serum Lipoprotein Function in Patients with Rheumatoid Arthritis after Tocilizumab Treatment, a Pilot Study

Daniela Greco et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Add to Collection
Article Cardiac & Cardiovascular Systems

Colchicine in Patients With Acute Coronary Syndrome The Australian COPS Randomized Clinical Trial

David C. Tong et al.

CIRCULATION (2020)

Add to Collection
Article Cardiac & Cardiovascular Systems

Inhibition of Interleukin-1β and Reduction in Atherothrombotic Cardiovascular Events in the CANTOS Trial

Brendan M. Everett et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Add to Collection
Article Medicine, General & Internal

Colchicine in Patients with Chronic Coronary Disease

Stefan M. Nidorf et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection
Review Cell Biology

NLRP3 inflammasome in endothelial dysfunction

Baochen Bai et al.

CELL DEATH & DISEASE (2020)

Add to Collection
Article Food Science & Technology

Tocilizumab improves oxidative stress and endothelial glycocalyx: A mechanism that may explain the effects of biological treatment on COVID-19

Ignatios Ikonomidis et al.

FOOD AND CHEMICAL TOXICOLOGY (2020)

Add to Collection
Article Public, Environmental & Occupational Health

Interleukin-10 as a predictor of major adverse cardiovascular events in a racially and ethnically diverse population: Multi-Ethnic Study of Atherosclerosis

Deena Goldwater et al.

ANNALS OF EPIDEMIOLOGY (2019)

Add to Collection
Article Medical Laboratory Technology

Increased Inflammatory Activity in Patients 3 Months after Myocardial Infarction with Nonobstructive Coronary Arteries

Marcus Hjort et al.

CLINICAL CHEMISTRY (2019)

Add to Collection
Article Cardiac & Cardiovascular Systems

Neutralizing effects of anti-infliximab antibodies on synergistically-stimulated human coronary artery endothelial cells

Manca Ogric et al.

ATHEROSCLEROSIS (2019)

Add to Collection
Article Immunology

The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction

Rifeng Gao et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2019)

Add to Collection
Article Medicine, General & Internal

Atherosclerosis

Peter Libby et al.

NATURE REVIEWS DISEASE PRIMERS (2019)

Add to Collection
Article Biochemistry & Molecular Biology

Platelet-derived chemokines in inflammation and atherosclerosis

Constantinos Bakogiannis et al.

CYTOKINE (2019)

Add to Collection
Editorial Material Biochemistry & Molecular Biology

Inflammation in atherosclerosis: A key role for cytokines

Sibylle von Vietinghoff et al.

CYTOKINE (2019)

Add to Collection
Article Medicine, General & Internal

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

Jean-Claude Tardif et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection
Article Medicine, General & Internal

Low-Dose Methotrexate for the Prevention of Atherosclerotic Events

Paul M. Ridker et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection
Article Cardiac & Cardiovascular Systems

Effect of statins on atherosclerotic plaque

Shone O. Almeida et al.

TRENDS IN CARDIOVASCULAR MEDICINE (2019)

Add to Collection
Review Cardiac & Cardiovascular Systems

Reactive Oxygen Species in Metabolic and Inflammatory Signaling

Steven J. Forrester et al.

CIRCULATION RESEARCH (2018)

Add to Collection
Review Pharmacology & Pharmacy

Colchicine Pharmacokinetics and Mechanism of Action

Christos Angelidis et al.

CURRENT PHARMACEUTICAL DESIGN (2018)

Add to Collection
Article Medicine, General & Internal

Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes

F. De Benedetti et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Add to Collection
Article Biochemistry & Molecular Biology

Tocilizumab, a Humanized Monoclonal Antibody Against the Interleukin-6 Receptor, Inhibits High Glucose-Induced Vascular Smooth Muscle Cell Migration Through Mitogen-Activated Protein Kinase Signaling Pathways

Tao-Cheng Wu et al.

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2018)

Add to Collection
Article Medicine, General & Internal

Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017

Gregory A. Roth et al.

LANCET (2018)

Add to Collection
Article Rheumatology

The effect of TNF-a antagonists on aortic stiffness and wave reflections: a meta-analysis

C. Vlachopoulos et al.

CLINICAL RHEUMATOLOGY (2018)

Add to Collection
Article Cardiac & Cardiovascular Systems

Colchicine for prevention and treatment of cardiac diseases: A meta-analysis

Nikolaos Papageorgiou et al.

CARDIOVASCULAR THERAPEUTICS (2017)

Add to Collection
Review Cardiac & Cardiovascular Systems

Interleukin-1 Beta as a Target for Atherosclerosis Therapy Biological Basis of CANTOS and Beyond

Peter Libby

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Add to Collection
Article Physiology

Overexpression of Toll-Like Receptors 2, 3, 4, and 8 Is Correlated to the Vascular Atherosclerotic Process in the Hyperlipidemic Rabbit Model: The Effect of Statin Treatment

Alkistis Kapelouzou et al.

JOURNAL OF VASCULAR RESEARCH (2017)

Add to Collection
Review Cell Biology

Protective Effects of Methotrexate against Proatherosclerotic Cytokines: A Review of the Evidence

Arduino A. Mangoni et al.

MEDIATORS OF INFLAMMATION (2017)

Add to Collection
Article Medicine, General & Internal

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

P. M. Ridker et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Add to Collection
Review Pharmacology & Pharmacy

Statins and Inflammation in Cardiovascular Disease

Georgia Vogiatzi et al.

CURRENT PHARMACEUTICAL DESIGN (2017)

Add to Collection
Review Pharmacology & Pharmacy

Statins and Vulnerable Plaque

Maria Drakopoulou et al.

CURRENT PHARMACEUTICAL DESIGN (2017)

Add to Collection
Review Cardiac & Cardiovascular Systems

High-density Lipoprotein and Low-density Lipoprotein Therapeutic Approaches in Acute Coronary Syndromes

Emmanuel Androulakis et al.

CURRENT CARDIOLOGY REVIEWS (2017)

Add to Collection
Article Cardiac & Cardiovascular Systems

Cardiovascular Event Prediction by Machine Learning The Multi-Ethnic Study of Atherosclerosis

Bharath Ambale-Venkatesh et al.

CIRCULATION RESEARCH (2017)

Add to Collection
Article Hematology

NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report

Thomas van der Heijden et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)

Add to Collection
Editorial Material Hematology

The CANTOS Trial One Important Step for Clinical Cardiology but a Giant Leap for Vascular Biology

Richard A. Baylis et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)

Add to Collection
Review Cardiac & Cardiovascular Systems

Dysfunctional HDL and atherosclerotic cardiovascular disease

Robert S. Rosenson et al.

NATURE REVIEWS CARDIOLOGY (2016)

Add to Collection
Article Medicine, Research & Experimental

Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activation

Stacy Robertson et al.

CLINICAL SCIENCE (2016)

Add to Collection
Review Cardiac & Cardiovascular Systems

Inflammatory cytokines in atherosclerosis: current therapeutic approaches

Dimitris Tousoulis et al.

EUROPEAN HEART JOURNAL (2016)

Add to Collection
Review Pharmacology & Pharmacy

Cardiovascular outcomes and tumour necrosis factor antagonists in chronic inflammatory rheumatic disease: a focus on rheumatoid arthritis

Giuliano Tocci et al.

EXPERT OPINION ON DRUG SAFETY (2016)

Add to Collection
Article Cardiac & Cardiovascular Systems

Arterial Effects of Canakinumab in Patients With Atherosclerosis and Type 2 Diabetes or Glucose Intolerance

Robin P. Choudhury et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)

Add to Collection
Article Cardiac & Cardiovascular Systems

Statins and myocardial infarction: Type, dose, and administration time: Does it matter?

Nikolaos Papageorgiou et al.

TRENDS IN CARDIOVASCULAR MEDICINE (2016)

Add to Collection
Article Cardiac & Cardiovascular Systems

Comparative Safety of Interleukin-1 Blockade With Anakinra in Patients With ST-Segment Elevation Acute Myocardial Infarction (from the VCU-ART and VCU-ART2 Pilot Studies)

Antonio Abbate et al.

AMERICAN JOURNAL OF CARDIOLOGY (2015)

Add to Collection
Article Cardiac & Cardiovascular Systems

Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials

Amirhossein Sahebkar et al.

ATHEROSCLEROSIS (2015)

Add to Collection
Article Cardiac & Cardiovascular Systems

Anti-Inflammatory Treatment With Colchicine in Acute Myocardial Infarction A Pilot Study

Spyridon Deftereos et al.

CIRCULATION (2015)

Add to Collection
Article Biochemistry & Molecular Biology

Interferon gamma in autoimmunity: A complicated player on a complex stage

Jason R. Lees

CYTOKINE (2015)

Add to Collection
Article Hematology

Antiinflammatory effects of aspirin in ACS: relevant to its cardiocoronary actions?

Thomas Hohlfeld et al.

THROMBOSIS AND HAEMOSTASIS (2015)

Add to Collection
Article Medicine, General & Internal

NLRP3 and downstream cytokine expression elevated in the monocytes of patients with coronary artery disease

Lili Wang et al.

ARCHIVES OF MEDICAL SCIENCE (2014)

Add to Collection
Article Cardiac & Cardiovascular Systems

The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats

Susana Vallejo et al.

CARDIOVASCULAR DIABETOLOGY (2014)

Add to Collection
Article Cardiac & Cardiovascular Systems

Increased Benefit of Interleukin-1 Inhibition on Vascular Function, Myocardial Deformation, and Twisting in Patients With Coronary Artery Disease and Coexisting Rheumatoid Arthritis

Ignatios Ikonomidis et al.

CIRCULATION-CARDIOVASCULAR IMAGING (2014)

Add to Collection
Article Medicine, Research & Experimental

NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin

Mamoru Satoh et al.

CLINICAL SCIENCE (2014)

Add to Collection
Review Pharmacology & Pharmacy

Effects of Biologic Agents and Other Disease-Modifying Antirheumatic Drugs on Cardiovascular Outcomes in Psoriasis and Psoriatic Arthritis: A Systematic Review

April W. Armstrong et al.

CURRENT PHARMACEUTICAL DESIGN (2014)

Add to Collection
Article Cardiac & Cardiovascular Systems

Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis

Stephen Kaptoge et al.

EUROPEAN HEART JOURNAL (2014)

Add to Collection
Article Medicine, General & Internal

Lipid-lowering treatment and inflammatory mediators in diabetes and chronic kidney disease

Tora Almquist et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2014)

Add to Collection
Article Cardiac & Cardiovascular Systems

Effect of Atorvastatin Therapy on Fibrous Cap Thickness in Coronary Atherosclerotic Plaque as Assessed by Optical Coherence Tomography

Kenichi Komukai et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)

Add to Collection
Article Cardiac & Cardiovascular Systems

Innate and Adaptive Inflammation as a Therapeutic Target in Vascular Disease

Dimitris Tousoulis et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)

Add to Collection
Review Hematology

Impact of vascular thromboxane prostanoid receptor activation on hemostasis, thrombosis, oxidative stress, and inflammation

V. Capra et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)

Add to Collection
Article Cardiac & Cardiovascular Systems

Circulating Myeloid-Related Protein-8/14 is Related to Thromboxane-Dependent Platelet Activation in Patients With Acute Coronary Syndrome, With and Without Ongoing Low-Dose Aspirin Treatment

Francesca Santilli et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)

Add to Collection
Article Biochemistry & Molecular Biology

Effects of the dual TP receptor antagonist and thromboxane synthase inhibitor EV-077 on human endothelial and vascular smooth muscle cells

Marcelo H. Petri et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)

Add to Collection
Article Hematology

A vasculo-protective circuit centered on lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 operative in murine microcirculation

Vincenzo Brancaleone et al.

BLOOD (2013)

Add to Collection
Article Cardiac & Cardiovascular Systems

Efficacy of the CCR5 Antagonist Maraviroc in Reducing Early, Ritonavir-Induced Atherogenesis and Advanced Plaque Progression in Mice

Sabrina Cipriani et al.

CIRCULATION (2013)

Add to Collection
Article Cardiac & Cardiovascular Systems

Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease

Stefan M. Nidorf et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)

Add to Collection
Review Immunology

Activation and regulation of the inflammasomes

Eicke Latz et al.

NATURE REVIEWS IMMUNOLOGY (2013)

Add to Collection
Article Biochemistry & Molecular Biology

Interleukin 6 destabilizes atherosclerotic plaques by downregulating prolyl-4-hydroxylase α1 via a mitogen-activated protein kinase and c-Jun pathway

Ke Zhang et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2012)

Add to Collection
Article Hematology

Transsignaling of Interleukin-6 Crucially Contributes to Atherosclerosis in Mice

Harald Schuett et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)

Add to Collection
Article Hematology

Inflammation in Atherosclerosis

Peter Libby

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)

Add to Collection
Article Pharmacology & Pharmacy

The Role of Nitric Oxide on Endothelial Function

Dimitris Tousoulis et al.

CURRENT VASCULAR PHARMACOLOGY (2012)

Add to Collection
Article Medicine, General & Internal

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis

Daniel I. Swerdlow et al.

LANCET (2012)

Add to Collection
Article Cardiac & Cardiovascular Systems

Relationship between circulating levels of RANTES (regulated on activation, normal T-cell expressed, and secreted) and carotid plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study

Salim S. Virani et al.

EUROPEAN HEART JOURNAL (2011)

Add to Collection
Letter Cardiac & Cardiovascular Systems

Anti-tumor necrosis factor alpha treatment with adalimumab improves significantly endothelial function and decreases inflammatory process in patients with chronic psoriasis

Georgia Avgerinou et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)

Add to Collection
Review Rheumatology

Systematic Review and Meta-Analysis: Anti-Tumor Necrosis Factor α Therapy and Cardiovascular Events in Rheumatoid Arthritis

Cheryl Barnabe et al.

ARTHRITIS CARE & RESEARCH (2011)

Add to Collection
Article Cardiac & Cardiovascular Systems

Aspirin Adherence, Aspirin Dosage, and C-Reactive Protein in the First 3 Months After Acute Coronary Syndrome

Ian M. Kronish et al.

AMERICAN JOURNAL OF CARDIOLOGY (2010)

Add to Collection
Article Genetics & Heredity

Thromboxane synthase expression and thromboxane A2 production in the atherosclerotic lesion

Anders Gabrielsen et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2010)

Add to Collection
Article Medicine, Research & Experimental

Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction

Christian Stumpf et al.

CLINICAL SCIENCE (2009)

Add to Collection
Article Immunology

Effects of Low-Dose Aspirin on Acute Inflammatory Responses in Humans

Thea Morris et al.

JOURNAL OF IMMUNOLOGY (2009)

Add to Collection
Article Biochemistry & Molecular Biology

Activation-dependent stabilization of the human thromboxane receptor: role of reactive oxygen species

Stephen J. Wilson et al.

JOURNAL OF LIPID RESEARCH (2009)

Add to Collection
Review Biochemistry & Molecular Biology

Biomarkers of premature atherosclerosis

Anna-Maria Kampoli et al.

TRENDS IN MOLECULAR MEDICINE (2009)

Add to Collection
Review Cardiac & Cardiovascular Systems

Prostanoid and isoprostanoid pathways in atherogenesis

Domenico Pratico

ATHEROSCLEROSIS (2008)

Add to Collection
Article Cardiac & Cardiovascular Systems

Incomplete Inhibition of Thromboxane Biosynthesis by Acetylsalicylic Acid Determinants and Effect on Cardiovascular Risk

John W. Eikelboom et al.

CIRCULATION (2008)

Add to Collection
Article Medicine, General & Internal

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Paul M. Ridker et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Add to Collection
Article Cardiac & Cardiovascular Systems

Mechanism of TNFα-induced IL-1α, IL-1β and IL-6 expression in human cardiac fibroblasts:: Effects of statins and thiazolidinediones

Neil A. Turner et al.

CARDIOVASCULAR RESEARCH (2007)

Add to Collection
Article Cardiac & Cardiovascular Systems

Inhibition of progression and stabilization of plaques by postnatal interferon-γ function blocking in ApoE-Knockout mice

Mitsuhisa Koga et al.

CIRCULATION RESEARCH (2007)

Add to Collection
Letter Cardiac & Cardiovascular Systems

Effects of atorvastatin and vitamin C on forearm hyperaemic blood flow, asymmentrical dimethylarginine levels and the inflammatory process in patients with type 2 diabetes mellitus

Dimitris Tousoulis et al.

HEART (2007)

Add to Collection
Article Hematology

No difference in the effects of clopidogrel and aspirin on inflammatory markers in patients with coronary heart disease

Svein Solheim et al.

THROMBOSIS AND HAEMOSTASIS (2006)

Add to Collection
Review Medicine, General & Internal

Drug therapy -: Low-dose aspirin for the prevention of atherothrombosis

C Patrono et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Add to Collection
Article Peripheral Vascular Disease

Effects of low-dose aspirin on blood pressure and endothelial function of treated hypertensive hypercholesterolaemic subjects

E Magen et al.

JOURNAL OF HUMAN HYPERTENSION (2005)

Add to Collection
Article Cardiac & Cardiovascular Systems

Disruption of tumor necrosis factor-α gene diminishes the development of atherosclerosis in ApoE-deficient mice

H Ohta et al.

ATHEROSCLEROSIS (2005)

Add to Collection
Article Cardiac & Cardiovascular Systems

Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: Effects of aspirin treatment

I Ikonomidis et al.

AMERICAN HEART JOURNAL (2005)

Add to Collection
Article Cardiac & Cardiovascular Systems

Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice

NR Veillard et al.

CIRCULATION RESEARCH (2004)

Add to Collection
Article Pharmacology & Pharmacy

Aspirin induces nitric oxide release from vascular endothelium:: a novel mechanism of action

D Taubert et al.

BRITISH JOURNAL OF PHARMACOLOGY (2004)

Add to Collection
Article Cardiac & Cardiovascular Systems

Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis

B Schieffer et al.

CIRCULATION (2004)

Add to Collection
Article Cardiac & Cardiovascular Systems

Intramuscular gene transfer of interleukin-10 cDNA reduces atherosclerosis in apolipoprotein E-knockout mice

M Namiki et al.

ATHEROSCLEROSIS (2004)

Add to Collection
Article Hematology

A randomized comparison of the effects of aspirin and clopidogrel on thrombotic risk factors and C-reactive protein following myocardial infarction: the ADET trial

M Woodward et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)

Add to Collection
Article Multidisciplinary Sciences

Aspirin triggers anti inflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial

N Chiang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Add to Collection
Article Cardiac & Cardiovascular Systems

Aspirin modifies nitric oxide synthase activity in platelets: effects of acute versus chronic aspirin treatment

PD O'Kane et al.

CARDIOVASCULAR RESEARCH (2003)

Add to Collection
Article Hematology

Influence of interferon-γ on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse

C Buono et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)

Add to Collection
Article Medicine, General & Internal

Inflammatory imbalance between IL-10 and TNFα in unstable angina potential plaque stabilizing effects of IL-10

T Wæhre et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2002)

Add to Collection
Article Multidisciplinary Sciences

Structural mechanism for statin inhibition of HMG-CoA reductase

ES Istvan et al.

SCIENCE (2001)

Add to Collection
Article Cardiac & Cardiovascular Systems

RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium

P von Hundelshausen et al.

CIRCULATION (2001)

Add to Collection
Article Hematology

The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice - Evidence that eicosanoids other than thromboxane contribute to atherosclerosis

AJ Cayatte et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.